Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cytochrome P450 family 3 subfamily A member 7 (CYP3A7) small molecule antagonists: luciferase cell-based qHTS assay
Assay data:2481 Active, 355 Activity ≤ 1 µM, 5246 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Depositor
p53 small molecule agonists, cell-based qHTS assay with human liver microsomes: Summary
Assay data:70 Active, 12 Activity ≤ 1 µM, 9667 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same Project
p53 small molecule agonists, cell-based qHTS assay: Summary
Assay data:212 Active, 41 Activity ≤ 1 µM, 9667 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Same Project
p53 small molecule agonists, cell-based qHTS assay with rat liver microsomes: Summary
Assay data:103 Active, 14 Activity ≤ 1 µM, 9667 Tested
p53 small molecule agonists, cell-based qHTS assay
Assay data:87 Active, 5 Activity ≤ 1 nM, 180 Activity ≤ 1 µM, 9667 Tested
FABP3, FABP5, and FABP7 Binding Assay from US Patent US20230365488: "TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF"
Assay data:47 Active, 22 Activity ≤ 1 µM, 47 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Nuclear factor erythroid 2-related factor 2/antioxidant responsive element (Nrf2/ARE) small molecule agonists: luciferase reporter gene qHTS assay in human keratinocytes
Assay data:1099 Active, 1 Activity ≤ 1 nM, 143 Activity ≤ 1 µM, 9667 Tested
Inhibition of FAPα In Vitro Enzymatic Activity Assay from US Patent US11504364: "Inhibitors of fibroblast activation protein"
Assay data:3 Active, 3 Activity ≤ 1 µM, 58 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Inhibitory Activity Assay from US Patent US11078214: "Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same"
Assay data:17 Active, 17 Activity ≤ 1 µM, 17 Tested
Receptor Activity Assay from US Patent US10633388: "Pyrazolopyrimidone derivatives and methods of use thereof"
Assay data:14 Active, 11 Activity ≤ 1 nM, 14 Activity ≤ 1 µM, 14 Tested
Z-LYTE biochemical assay from Article 10.1111/cbdd.12243: "Design, synthesis and biological evaluation of pazopanib derivatives as antitumor agents."
Assay data:12 Active, 11 Activity ≤ 1 µM, 12 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
BP Incorporation Assay from Article 10.1016/j.chembiol.2008.07.015: "Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries."
Assay data:6 Active, 2 Activity ≤ 1 µM, 9 Tested
Tyrosine Kinase Assay from Article 10.1038/nchembio.117: "Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases."
Assay data:3 Active, 2 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Dose required to inhibit HIV-1 reverse transcriptase activity (Y188L mutant) by 50%
Assay data:1 Active, 1 Activity ≤ 1 µM, 4 Tested
Dose required to inhibit HIV-1 reverse transcriptase activity (Y181I mutant) by 50%
Assay data:2 Active, 1 Activity ≤ 1 µM, 4 Tested
Dose required to inhibit HIV-1 reverse transcriptase activity (V179D mutant) by 50%
Concentration that inhibits cellular growth of MT-4 cells acutely infected with HIV-1 RFstrain by 50%
Assay data:15 Active, 15 Activity ≤ 1 µM, 20 Tested
Induction of human wild type STING in PBMC assessed as induced secretion of IFNbeta
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of ABAD (unknown origin) assessed as residual activity using acetoacetyl-CoA in presence of NADH by spectrophotometric assay relative to control
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Inhibition of ABAD (unknown origin) by cell based assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on